Nissen headed a multi-center trial to see if the drug could reduce cholesterol buildup in arteries.

NPR: Deaths Prompted Withdrawal of Cholesterol Drug

The randomized, double-blind, placebo-controlled, multi-center trial enrolled 51 patients age 12 to 53 years, including 7 patients age 12 to 16 years, who were maintaining a regimen of maximally-tolerated lipid lowering medications.

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

At a conference of gastroenterologists in San Diego on Monday, researchers presented interim results from a multi-center trial showing that among patients treated with RFA, 85% were free of dysplasia, and 74% were free of all signs of Barrett's, 12 months later.

WSJ: Esophageal Therapy You Can Stomach

The Symplicity HTN-2 trial is an international, multi-center, prospective, randomized, controlled study of renal denervation in patients with treatment-resistant hypertension.

FORBES: Promising One Year Results For Renal Denervation In Resistant Hypertension Spark Hype